Designing Personalized Treatment: An Application to Anticoagulation Therapy

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Production and Operations Management

• Publication date

  2016-05-01

• Fields of study

  Medicine, Computer Science

• Identifiers
  DOI 10.1111/poms.12514
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Partially Observable Markov Decision Processes

  2017cited by this paper
• Pattern Recognition And Machine Learning

  2016influential reference
• National Institute for Health and Care Excellence.

  2015cited by this paper
• Learning Stroke Treatment Progression Models for an MDP Clinical Decision Support System

  2015cited by this paper
• Update on Genetic Testing and Warfarin

  2014cited by this paper
• The Effect of Budgetary Restrictions on Breast Cancer Diagnostic Decisions

  2012cited by this paper
• Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

  2012cited by this paper
• Introduction to the OR Forum Article: "A POMDP Approach to Personalize Mammography Screening Decisions" by Turgay Ayer, Oguzhan Alagoz, and Natasha K. Stout

  2012cited by this paper
• OR Forum - A POMDP Approach to Personalize Mammography Screening Decisions

  2012cited by this paper
• Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

  2012cited by this paper
• Study of Warfarin Patients Investigating Attitudes Toward Therapy Change (SWITCH Survey)

  2012cited by this paper
• Medical decision making: open research challenges

  2011cited by this paper
• Risks for Stroke, Bleeding, and Death in Patients With Atrial Fibrillation Receiving Dabigatran or Warfarin in Relation to the CHADS2 Score: A Subgroup Analysis of the RE-LY Trial

  2011cited by this paper
• Influence of genetic, biological and pharmacological factors on warfarin dose in a Southern Brazilian population of European ancestry.

  2011influential reference
• Transportation Cost of Anticoagulation Clinic Visits in an Urban Setting

  2011cited by this paper
• Optimal Breast Biopsy Decision-Making Based on Mammographic Features and Demographic Factors

  2010cited by this paper
• Optimal control of dosage decisions in controlled ovarian hyperstimulation

  2010cited by this paper
• Partially Observable Markov Decision Processes

  2010cited by this paper
• Patient Factors That Influence Warfarin Dose Response

  2010cited by this paper
• The long and winding road to warfarin pharmacogenetic testing.

  2010cited by this paper
• Estimation of the warfarin dose with clinical and pharmacogenetic data.

  2009influential reference
• Warfarin sensitivity genotyping: a review of the literature and summary of patient experience.

  2009cited by this paper
• Outcomes and predictors of very stable INR control during chronic anticoagulation therapy.

  2009cited by this paper
• Medical decision making for patients with Parkinson disease under Average Cost Criterion

  2009cited by this paper
• Cost-Effectiveness of Genotype-Guided Warfarin Dosing for Patients With Atrial Fibrillation

  2009cited by this paper
• Assessing Dynamic Breast Cancer Screening Policies

  2008cited by this paper
• The Optimal Time to Initiate HIV Therapy Under Ordered Health States

  2008cited by this paper
• Choosing Among Living-Donor and Cadaveric Livers

  2007cited by this paper
• Genetic-based dosing in orthopedic patients beginning warfarin therapy.

  2007cited by this paper
• Major Hemorrhage and Tolerability of Warfarin in the First Year of Therapy Among Elderly Patients With Atrial Fibrillation

  2007cited by this paper
• A Survey of Partially Observable Markov Decision Processes: Theory, Models, and Algorithms

  2007cited by this paper
• Optimal INR for prevention of stroke and death in atrial fibrillation: a critical appraisal.

  2006influential reference
• Modeling Medical Treatment Using Markov Decision Processes

  2005cited by this paper
• Operations research and health care : a handbook of methods and applications

  2004cited by this paper
• Practical tips for warfarin dosing and monitoring.

  2003cited by this paper
• Cost-Effectiveness of Colorectal Cancer Screening in the Average Risk Population

  2003cited by this paper
• POMDP solution methods

  2003cited by this paper
• Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation.

  2003cited by this paper
• The path to personalized medicine.

  2002cited by this paper
• Managing oral anticoagulant therapy.

  2001cited by this paper
• Planning treatment of ischemic heart disease with partially observable Markov decision processes

  2000cited by this paper
• Dynamic Programming

  1993cited by this paper
• A Method to Determine the Optimal Intensity of Oral Anticoagulant Therapy

  1993cited by this paper
• The Optimal Control of Partially Observable Markov Processes over a Finite Horizon

  1973cited by this paper

• Contextual Learning with Online Convex Optimization: Theory and Application to Medical Decision-Making

  2025cites this paper
• A user-customizable hybrid framework for targeted medical decision-making.

  2025cites this paper
• Optimal Payment for Dynamic Treatment Regimes

  2024cites this paper
• Toward an Integrated Decision-Making Framework for Optimized Stroke Diagnosis with DSA and Treatment under Uncertainty

  2024cites this paper
• Data-Driven Allocation of Preventive Care With Application to Diabetes Mellitus Type II

  2023cites this paper
• A functional Hidden Markov Model to incorporate dynamics into Bayesian optimal stopping problems: Helping physicians manage traumatic brain injuries

  2023cites this paper
• Diagnostic Policies Optimization for Chronic Diseases Based on POMDP Model

  2022cites this paper
• An Analytics Approach to Guide Randomized Controlled Trials in Hypertension Management

  2022cites this paper
• Data-driven dynamic treatment planning for chronic diseases

  2022influential citation
• Learning Dynamics and Control of a Stochastic System under Limited Sensing Capabilities

  2022cites this paper
• Algorithmic fairness in business analytics: Directions for research and practice

  2022cites this paper
• A Promising Approach to Optimizing Sequential Treatment Decisions for Depression: Markov Decision Process

  2022influential citation
• Formalizing Cognitive Biases in Diagnostic Reasoning

  2022cites this paper
• An Analytics‐Driven Approach for Optimal Individualized Diabetes Screening

  2021cites this paper
• Personalized Cotesting Policies for Cervical Cancer Screening: A POMDP Approach

  2021cites this paper
• Product personalization and firm performance: An empirical analysis of the pharmaceutical industry

  2020cites this paper
• Optimal coinsurance rates for a heterogeneous population under inequality and resource constraints

  2019cites this paper
• The Forest or the Trees? Tackling Simpson's Paradox with Classification Trees

  2018cites this paper
• Preference‐Sensitive Management of Post‐Mammography Decisions in Breast Cancer Diagnosis

  2018cites this paper
• Optimal M-Switch Surveillance Policies for Liver Cancer in a Hepatitis C-Infected Population

  2018cites this paper
• Designing Risk‐Adjusted Therapy for Patients with Hypertension

  2018cites this paper
• Timing the Use of Breast Cancer Risk Information in Biopsy Decision‐Making

  2017cites this paper
• The Routledge Companion to Production and Operations Management

  2017cites this paper